Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Systemic sclerosis].

U Müller-Ladner1

  • 1Lehrstuhl für Innere Medizin mit Schwerpunkt Rheumatologie, Justus-Liebig-Universität, Giessen. u.mueller-ladner@kerckhoff-klinik.de

Der Internist
|January 23, 2008
PubMed
Summary
This summary is machine-generated.

Systemic sclerosis involves abnormal immune activation leading to matrix synthesis, not inflammation. Early monitoring using clinical and lab markers is crucial for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis and treatment of ANCA-associated vasculitis : S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for ENT Medicine and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]

Zeitschrift fur Rheumatologie·2025
Same author

[Diagnosis and treatment of ANCA-associated vasculitis : SHORT VERSION of the S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for Otorhinolaryngology and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]

Zeitschrift fur Rheumatologie·2025
Same author

Castleman's disease in the rheumatological practice.

Zeitschrift fur Rheumatologie·2024
Same author

[Castleman's disease in the rheumatological practice].

Zeitschrift fur Rheumatologie·2023
Same author

The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany.

Rheumatology (Oxford, England)·2021
Same author

[Active vaccinations : One of the essential measures to maintain the health of our patients with rheumatic diseases].

Zeitschrift fur Rheumatologie·2020
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Area of Science:

  • Rheumatology and Clinical Immunology
  • Immunodermatology

Context:

  • Systemic sclerosis (SSc) is a complex autoimmune disease characterized by aberrant immune activation and excessive matrix synthesis, particularly in the skin.
  • Established networks like the German Network for Systemic Sclerosis (DNSS) and European Scleroderma Trials and Research (EUSTAR) provide detailed patient data.
  • Unlike inflammatory autoimmune diseases, SSc's pathology involves progressive fibrosis rather than immune-driven tissue destruction.

Purpose:

  • To highlight the unique pathophysiology of systemic sclerosis compared to other rheumatologic conditions.
  • To emphasize the importance of early detection and monitoring in managing SSc.
  • To identify the potential of clinical and laboratory parameters as predictive markers for disease progression and patient outcomes.

Summary:

Related Experiment Videos

  • Systemic sclerosis (SSc) presents a distinct immunological profile, marked by progressive matrix synthesis rather than inflammation-induced damage.
  • While specific early predictive markers remain elusive, Raynaud phenomenon can precede overt organ manifestations by a decade.
  • Distinct clinical features and laboratory findings serve as independent predictors for patient prognosis.

Impact:

  • Early and regular monitoring in preclinical and early SSc stages is vital for reducing patient morbidity and mortality.
  • Timely diagnosis facilitates proactive management of severe complications such as pulmonary hypertension, digital ischemia, reflux esophagitis, and scleroderma renal crisis.
  • Understanding SSc's unique disease course allows for tailored patient management strategies and improved long-term outcomes.